Idelalisib Market In Global
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of ... Read More
1 Introduction to Research & Analysis Reports 1.1 Ipatasertib Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Ipatasertib Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Ipatasertib Overall Market Size 2.1 Global Ipatasertib Market Size: 2021 VS 2028 2.2 Global Ipatasertib Revenue, Prospects & Forecasts: 2017-2028 2.3 Global Ipatasertib Sales: 2017-2028 3 Company Landscape 3.1 Top Ipatasertib Players in Global Market 3.2 Top Global Ipatasertib Companies Ranked by Revenue 3.3 Global Ipatasertib Revenue by Companies 3.4 Global Ipatasertib Sales by Companies 3.5 Global Ipatasertib Price by Manufacturer (2017-2022) 3.6 Top 3 and Top 5 Ipatasertib Companies in Global Market, by Revenue in 2021 3.7 Global Manufacturers Ipatasertib Product Type 3.8 Tier 1, Tier 2 and Tier 3 Ipatasertib Players in Global Market 3.8.1 List of Global Tier 1 Ipatasertib Companies 3.8.2 List of Global Tier 2 and Tier 3 Ipatasertib Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Ipatasertib Market Size Markets, 2021 & 2028 4.1.2 Min Purity Less Than 98% 4.1.3 Min Purity 98%-99% 4.1.4 Min Purity More Than 99% 4.2 By Type - Global Ipatasertib Revenue & Forecasts 4.2.1 By Type - Global Ipatasertib Revenue, 2017-2022 4.2.2 By Type - Global Ipatasertib Revenue, 2023-2028 4.2.3 By Type - Global Ipatasertib Revenue Market Share, 2017-2028 4.3 By Type - Global Ipatasertib Sales & Forecasts 4.3.1 By Type - Global Ipatasertib Sales, 2017-2022 4.3.2 By Type - Global Ipatasertib Sales, 2023-2028 4.3.3 By Type - Global Ipatasertib Sales Market Share, 2017-2028 4.4 By Type - Global Ipatasertib Price (Manufacturers Selling Prices), 2017-2028 5 Sights By Application 5.1 Overview 5.1.1 By Application - Global Ipatasertib Market Size, 2021 & 2028 5.1.2 Research 5.1.3 Medical 5.2 By Application - Global Ipatasertib Revenue & Forecasts 5.2.1 By Application - Global Ipatasertib Revenue, 2017-2022 5.2.2 By Application - Global Ipatasertib Revenue, 2023-2028 5.2.3 By Application - Global Ipatasertib Revenue Market Share, 2017-2028 5.3 By Application - Global Ipatasertib Sales & Forecasts 5.3.1 By Application - Global Ipatasertib Sales, 2017-2022 5.3.2 By Application - Global Ipatasertib Sales, 2023-2028 5.3.3 By Application - Global Ipatasertib Sales Market Share, 2017-2028 5.4 By Application - Global Ipatasertib Price (Manufacturers Selling Prices), 2017-2028 6 Sights by Region 6.1 By Region - Global Ipatasertib Market Size, 2021 & 2028 6.2 By Region - Global Ipatasertib Revenue & Forecasts 6.2.1 By Region - Global Ipatasertib Revenue, 2017-2022 6.2.2 By Region - Global Ipatasertib Revenue, 2023-2028 6.2.3 By Region - Global Ipatasertib Revenue Market Share, 2017-2028 6.3 By Region - Global Ipatasertib Sales & Forecasts 6.3.1 By Region - Global Ipatasertib Sales, 2017-2022 6.3.2 By Region - Global Ipatasertib Sales, 2023-2028 6.3.3 By Region - Global Ipatasertib Sales Market Share, 2017-2028 6.4 North America 6.4.1 By Country - North America Ipatasertib Revenue, 2017-2028 6.4.2 By Country - North America Ipatasertib Sales, 2017-2028 6.4.3 US Ipatasertib Market Size, 2017-2028 6.4.4 Canada Ipatasertib Market Size, 2017-2028 6.4.5 Mexico Ipatasertib Market Size, 2017-2028 6.5 Europe 6.5.1 By Country - Europe Ipatasertib Revenue, 2017-2028 6.5.2 By Country - Europe Ipatasertib Sales, 2017-2028 6.5.3 Germany Ipatasertib Market Size, 2017-2028 6.5.4 France Ipatasertib Market Size, 2017-2028 6.5.5 U.K. Ipatasertib Market Size, 2017-2028 6.5.6 Italy Ipatasertib Market Size, 2017-2028 6.5.7 Russia Ipatasertib Market Size, 2017-2028 6.5.8 Nordic Countries Ipatasertib Market Size, 2017-2028 6.5.9 Benelux Ipatasertib Market Size, 2017-2028 6.6 Asia 6.6.1 By Region - Asia Ipatasertib Revenue, 2017-2028 6.6.2 By Region - Asia Ipatasertib Sales, 2017-2028 6.6.3 China Ipatasertib Market Size, 2017-2028 6.6.4 Japan Ipatasertib Market Size, 2017-2028 6.6.5 South Korea Ipatasertib Market Size, 2017-2028 6.6.6 Southeast Asia Ipatasertib Market Size, 2017-2028 6.6.7 India Ipatasertib Market Size, 2017-2028 6.7 South America 6.7.1 By Country - South America Ipatasertib Revenue, 2017-2028 6.7.2 By Country - South America Ipatasertib Sales, 2017-2028 6.7.3 Brazil Ipatasertib Market Size, 2017-2028 6.7.4 Argentina Ipatasertib Market Size, 2017-2028 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Ipatasertib Revenue, 2017-2028 6.8.2 By Country - Middle East & Africa Ipatasertib Sales, 2017-2028 6.8.3 Turkey Ipatasertib Market Size, 2017-2028 6.8.4 Israel Ipatasertib Market Size, 2017-2028 6.8.5 Saudi Arabia Ipatasertib Market Size, 2017-2028 6.8.6 UAE Ipatasertib Market Size, 2017-2028 7 Manufacturers & Brands Profiles 7.1 Abcam 7.1.1 Abcam Corporate Summary 7.1.2 Abcam Business Overview 7.1.3 Abcam Ipatasertib Major Product Offerings 7.1.4 Abcam Ipatasertib Sales and Revenue in Global (2017-2022) 7.1.5 Abcam Key News 7.2 Cayman Chemical 7.2.1 Cayman Chemical Corporate Summary 7.2.2 Cayman Chemical Business Overview 7.2.3 Cayman Chemical Ipatasertib Major Product Offerings 7.2.4 Cayman Chemical Ipatasertib Sales and Revenue in Global (2017-2022) 7.2.5 Cayman Chemical Key News 7.3 Selleck Chemicals 7.3.1 Selleck Chemicals Corporate Summary 7.3.2 Selleck Chemicals Business Overview 7.3.3 Selleck Chemicals Ipatasertib Major Product Offerings 7.3.4 Selleck Chemicals Ipatasertib Sales and Revenue in Global (2017-2022) 7.3.5 Selleck Chemicals Key News 7.4 BOC Sciences 7.4.1 BOC Sciences Corporate Summary 7.4.2 BOC Sciences Business Overview 7.4.3 BOC Sciences Ipatasertib Major Product Offerings 7.4.4 BOC Sciences Ipatasertib Sales and Revenue in Global (2017-2022) 7.4.5 BOC Sciences Key News 7.5 BioVision 7.5.1 BioVision Corporate Summary 7.5.2 BioVision Business Overview 7.5.3 BioVision Ipatasertib Major Product Offerings 7.5.4 BioVision Ipatasertib Sales and Revenue in Global (2017-2022) 7.5.5 BioVision Key News 7.6 Adooq Bioscience 7.6.1 Adooq Bioscience Corporate Summary 7.6.2 Adooq Bioscience Business Overview 7.6.3 Adooq Bioscience Ipatasertib Major Product Offerings 7.6.4 Adooq Bioscience Ipatasertib Sales and Revenue in Global (2017-2022) 7.6.5 Adooq Bioscience Key News 7.7 Focus Biomolecules 7.7.1 Focus Biomolecules Corporate Summary 7.7.2 Focus Biomolecules Business Overview 7.7.3 Focus Biomolecules Ipatasertib Major Product Offerings 7.7.4 Focus Biomolecules Ipatasertib Sales and Revenue in Global (2017-2022) 7.7.5 Focus Biomolecules Key News 7.8 Biorbyt 7.8.1 Biorbyt Corporate Summary 7.8.2 Biorbyt Business Overview 7.8.3 Biorbyt Ipatasertib Major Product Offerings 7.8.4 Biorbyt Ipatasertib Sales and Revenue in Global (2017-2022) 7.8.5 Biorbyt Key News 7.9 AbMole 7.9.1 AbMole Corporate Summary 7.9.2 AbMole Business Overview 7.9.3 AbMole Ipatasertib Major Product Offerings 7.9.4 AbMole Ipatasertib Sales and Revenue in Global (2017-2022) 7.9.5 AbMole Key News 7.10 LifeSpan BioSciences 7.10.1 LifeSpan BioSciences Corporate Summary 7.10.2 LifeSpan BioSciences Business Overview 7.10.3 LifeSpan BioSciences Ipatasertib Major Product Offerings 7.10.4 LifeSpan BioSciences Ipatasertib Sales and Revenue in Global (2017-2022) 7.10.5 LifeSpan BioSciences Key News 7.11 MyBiosource 7.11.1 MyBiosource Corporate Summary 7.11.2 MyBiosource Ipatasertib Business Overview 7.11.3 MyBiosource Ipatasertib Major Product Offerings 7.11.4 MyBiosource Ipatasertib Sales and Revenue in Global (2017-2022) 7.11.5 MyBiosource Key News 7.12 LGC 7.12.1 LGC Corporate Summary 7.12.2 LGC Ipatasertib Business Overview 7.12.3 LGC Ipatasertib Major Product Offerings 7.12.4 LGC Ipatasertib Sales and Revenue in Global (2017-2022) 7.12.5 LGC Key News 7.13 MuseChem 7.13.1 MuseChem Corporate Summary 7.13.2 MuseChem Ipatasertib Business Overview 7.13.3 MuseChem Ipatasertib Major Product Offerings 7.13.4 MuseChem Ipatasertib Sales and Revenue in Global (2017-2022) 7.13.5 MuseChem Key News 7.14 Shimadzu 7.14.1 Shimadzu Corporate Summary 7.14.2 Shimadzu Business Overview 7.14.3 Shimadzu Ipatasertib Major Product Offerings 7.14.4 Shimadzu Ipatasertib Sales and Revenue in Global (2017-2022) 7.14.5 Shimadzu Key News 7.15 Taiclone 7.15.1 Taiclone Corporate Summary 7.15.2 Taiclone Business Overview 7.15.3 Taiclone Ipatasertib Major Product Offerings 7.15.4 Taiclone Ipatasertib Sales and Revenue in Global (2017-2022) 7.15.5 Taiclone Key News 7.16 Aladdin 7.16.1 Aladdin Corporate Summary 7.16.2 Aladdin Business Overview 7.16.3 Aladdin Ipatasertib Major Product Offerings 7.16.4 Aladdin Ipatasertib Sales and Revenue in Global (2017-2022) 7.16.5 Aladdin Key News 8 Global Ipatasertib Production Capacity, Analysis 8.1 Global Ipatasertib Production Capacity, 2017-2028 8.2 Ipatasertib Production Capacity of Key Manufacturers in Global Market 8.3 Global Ipatasertib Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Ipatasertib Supply Chain Analysis 10.1 Ipatasertib Industry Value Chain 10.2 Ipatasertib Upstream Market 10.3 Ipatasertib Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Ipatasertib Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer
List of Tables Table 1. Key Players of Ipatasertib in Global Market Table 2. Top Ipatasertib Players in Global Market, Ranking by Revenue (2021) Table 3. Global Ipatasertib Revenue by Companies, (US$, Mn), 2017-2022 Table 4. Global Ipatasertib Revenue Share by Companies, 2017-2022 Table 5. Global Ipatasertib Sales by Companies, (Kg), 2017-2022 Table 6. Global Ipatasertib Sales Share by Companies, 2017-2022 Table 7. Key Manufacturers Ipatasertib Price (2017-2022) & (K USD/Kg) Table 8. Global Manufacturers Ipatasertib Product Type Table 9. List of Global Tier 1 Ipatasertib Companies, Revenue (US$, Mn) in 2021 and Market Share Table 10. List of Global Tier 2 and Tier 3 Ipatasertib Companies, Revenue (US$, Mn) in 2021 and Market Share Table 11. By Type – Global Ipatasertib Revenue, (US$, Mn), 2021 & 2028 Table 12. By Type - Global Ipatasertib Revenue (US$, Mn), 2017-2022 Table 13. By Type - Global Ipatasertib Revenue (US$, Mn), 2023-2028 Table 14. By Type - Global Ipatasertib Sales (Kg), 2017-2022 Table 15. By Type - Global Ipatasertib Sales (Kg), 2023-2028 Table 16. By Application – Global Ipatasertib Revenue, (US$, Mn), 2021 & 2028 Table 17. By Application - Global Ipatasertib Revenue (US$, Mn), 2017-2022 Table 18. By Application - Global Ipatasertib Revenue (US$, Mn), 2023-2028 Table 19. By Application - Global Ipatasertib Sales (Kg), 2017-2022 Table 20. By Application - Global Ipatasertib Sales (Kg), 2023-2028 Table 21. By Region – Global Ipatasertib Revenue, (US$, Mn), 2021 VS 2028 Table 22. By Region - Global Ipatasertib Revenue (US$, Mn), 2017-2022 Table 23. By Region - Global Ipatasertib Revenue (US$, Mn), 2023-2028 Table 24. By Region - Global Ipatasertib Sales (Kg), 2017-2022 Table 25. By Region - Global Ipatasertib Sales (Kg), 2023-2028 Table 26. By Country - North America Ipatasertib Revenue, (US$, Mn), 2017-2022 Table 27. By Country - North America Ipatasertib Revenue, (US$, Mn), 2023-2028 Table 28. By Country - North America Ipatasertib Sales, (Kg), 2017-2022 Table 29. By Country - North America Ipatasertib Sales, (Kg), 2023-2028 Table 30. By Country - Europe Ipatasertib Revenue, (US$, Mn), 2017-2022 Table 31. By Country - Europe Ipatasertib Revenue, (US$, Mn), 2023-2028 Table 32. By Country - Europe Ipatasertib Sales, (Kg), 2017-2022 Table 33. By Country - Europe Ipatasertib Sales, (Kg), 2023-2028 Table 34. By Region - Asia Ipatasertib Revenue, (US$, Mn), 2017-2022 Table 35. By Region - Asia Ipatasertib Revenue, (US$, Mn), 2023-2028 Table 36. By Region - Asia Ipatasertib Sales, (Kg), 2017-2022 Table 37. By Region - Asia Ipatasertib Sales, (Kg), 2023-2028 Table 38. By Country - South America Ipatasertib Revenue, (US$, Mn), 2017-2022 Table 39. By Country - South America Ipatasertib Revenue, (US$, Mn), 2023-2028 Table 40. By Country - South America Ipatasertib Sales, (Kg), 2017-2022 Table 41. By Country - South America Ipatasertib Sales, (Kg), 2023-2028 Table 42. By Country - Middle East & Africa Ipatasertib Revenue, (US$, Mn), 2017-2022 Table 43. By Country - Middle East & Africa Ipatasertib Revenue, (US$, Mn), 2023-2028 Table 44. By Country - Middle East & Africa Ipatasertib Sales, (Kg), 2017-2022 Table 45. By Country - Middle East & Africa Ipatasertib Sales, (Kg), 2023-2028 Table 46. Abcam Corporate Summary Table 47. Abcam Ipatasertib Product Offerings Table 48. Abcam Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 49. Cayman Chemical Corporate Summary Table 50. Cayman Chemical Ipatasertib Product Offerings Table 51. Cayman Chemical Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 52. Selleck Chemicals Corporate Summary Table 53. Selleck Chemicals Ipatasertib Product Offerings Table 54. Selleck Chemicals Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 55. BOC Sciences Corporate Summary Table 56. BOC Sciences Ipatasertib Product Offerings Table 57. BOC Sciences Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 58. BioVision Corporate Summary Table 59. BioVision Ipatasertib Product Offerings Table 60. BioVision Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 61. Adooq Bioscience Corporate Summary Table 62. Adooq Bioscience Ipatasertib Product Offerings Table 63. Adooq Bioscience Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 64. Focus Biomolecules Corporate Summary Table 65. Focus Biomolecules Ipatasertib Product Offerings Table 66. Focus Biomolecules Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 67. Biorbyt Corporate Summary Table 68. Biorbyt Ipatasertib Product Offerings Table 69. Biorbyt Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 70. AbMole Corporate Summary Table 71. AbMole Ipatasertib Product Offerings Table 72. AbMole Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 73. LifeSpan BioSciences Corporate Summary Table 74. LifeSpan BioSciences Ipatasertib Product Offerings Table 75. LifeSpan BioSciences Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 76. MyBiosource Corporate Summary Table 77. MyBiosource Ipatasertib Product Offerings Table 78. MyBiosource Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 79. LGC Corporate Summary Table 80. LGC Ipatasertib Product Offerings Table 81. LGC Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 82. MuseChem Corporate Summary Table 83. MuseChem Ipatasertib Product Offerings Table 84. MuseChem Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 85. Shimadzu Corporate Summary Table 86. Shimadzu Ipatasertib Product Offerings Table 87. Shimadzu Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 88. Taiclone Corporate Summary Table 89. Taiclone Ipatasertib Product Offerings Table 90. Taiclone Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 91. Aladdin Corporate Summary Table 92. Aladdin Ipatasertib Product Offerings Table 93. Aladdin Ipatasertib Sales (Kg), Revenue (US$, Mn) and Average Price (K USD/Kg) (2017-2022) Table 94. Ipatasertib Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg) Table 95. Global Ipatasertib Capacity Market Share of Key Manufacturers, 2020-2022 Table 96. Global Ipatasertib Production by Region, 2017-2022 (Kg) Table 97. Global Ipatasertib Production by Region, 2023-2028 (Kg) Table 98. Ipatasertib Market Opportunities & Trends in Global Market Table 99. Ipatasertib Market Drivers in Global Market Table 100. Ipatasertib Market Restraints in Global Market Table 101. Ipatasertib Raw Materials Table 102. Ipatasertib Raw Materials Suppliers in Global Market Table 103. Typical Ipatasertib Downstream Table 104. Ipatasertib Downstream Clients in Global Market Table 105. Ipatasertib Distributors and Sales Agents in Global Market List of Figures Figure 1. Ipatasertib Segment by Type Figure 2. Ipatasertib Segment by Application Figure 3. Global Ipatasertib Market Overview: 2021 Figure 4. Key Caveats Figure 5. Global Ipatasertib Market Size: 2021 VS 2028 (US$, Mn) Figure 6. Global Ipatasertib Revenue, 2017-2028 (US$, Mn) Figure 7. Ipatasertib Sales in Global Market: 2017-2028 (Kg) Figure 8. The Top 3 and 5 Players Market Share by Ipatasertib Revenue in 2021 Figure 9. By Type - Global Ipatasertib Sales Market Share, 2017-2028 Figure 10. By Type - Global Ipatasertib Revenue Market Share, 2017-2028 Figure 11. By Type - Global Ipatasertib Price (K USD/Kg), 2017-2028 Figure 12. By Application - Global Ipatasertib Sales Market Share, 2017-2028 Figure 13. By Application - Global Ipatasertib Revenue Market Share, 2017-2028 Figure 14. By Application - Global Ipatasertib Price (K USD/Kg), 2017-2028 Figure 15. By Region - Global Ipatasertib Sales Market Share, 2017-2028 Figure 16. By Region - Global Ipatasertib Revenue Market Share, 2017-2028 Figure 17. By Country - North America Ipatasertib Revenue Market Share, 2017-2028 Figure 18. By Country - North America Ipatasertib Sales Market Share, 2017-2028 Figure 19. US Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 20. Canada Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 21. Mexico Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 22. By Country - Europe Ipatasertib Revenue Market Share, 2017-2028 Figure 23. By Country - Europe Ipatasertib Sales Market Share, 2017-2028 Figure 24. Germany Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 25. France Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 26. U.K. Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 27. Italy Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 28. Russia Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 29. Nordic Countries Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 30. Benelux Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 31. By Region - Asia Ipatasertib Revenue Market Share, 2017-2028 Figure 32. By Region - Asia Ipatasertib Sales Market Share, 2017-2028 Figure 33. China Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 34. Japan Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 35. South Korea Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 36. Southeast Asia Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 37. India Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 38. By Country - South America Ipatasertib Revenue Market Share, 2017-2028 Figure 39. By Country - South America Ipatasertib Sales Market Share, 2017-2028 Figure 40. Brazil Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 41. Argentina Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 42. By Country - Middle East & Africa Ipatasertib Revenue Market Share, 2017-2028 Figure 43. By Country - Middle East & Africa Ipatasertib Sales Market Share, 2017-2028 Figure 44. Turkey Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 45. Israel Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 46. Saudi Arabia Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 47. UAE Ipatasertib Revenue, (US$, Mn), 2017-2028 Figure 48. Global Ipatasertib Production Capacity (Kg), 2017-2028 Figure 49. The Percentage of Production Ipatasertib by Region, 2021 VS 2028 Figure 50. Ipatasertib Industry Value Chain Figure 51. Marketing Channels
115
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of ... Read More
2-Methyl-2-Pentenoic Acid is a carboxylic acid with the molecular formula C6H10O2, it is found in ... Read More
Buparlisib is an orally bioavailable and selective pan-class I phosphatidylinositol-3 kinase (PI3 ... Read More
Wortmannin is a potent, selective, cell-permeable and irreversible inhibitor of phosphatidylinosi ... Read More